| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/04/2013 | US8455489 Substituted pyrimidine compositions and methods of use |
| 06/04/2013 | US8455488 Alpha helix mimetics and methods relating thereto |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 05/30/2013 | US20130137867 Novel crystal of erlotinib base and the preparation method thereof |
| 05/30/2013 | US20130137711 Polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 05/30/2013 | US20130137709 Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith |
| 05/30/2013 | US20130137708 Methods and compositions for kinase inhibition |
| 05/30/2013 | US20130137706 Antimicrobial Molecules For Treating Multi-Drug Resistant and Extensively Drug Resistant Strains Of Mycobacterium |
| 05/30/2013 | US20130137699 Therapeutic compounds |
| 05/30/2013 | US20130137677 Bicyclic Azaheterocyclic Carboxamides |
| 05/30/2013 | US20130137673 Inhibitors of jak |
| 05/30/2013 | US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same |
| 05/30/2013 | US20130137635 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
| 05/30/2013 | US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 05/30/2013 | CA2856306A1 Selective kinase inhibitors |
| 05/30/2013 | CA2856301A1 Pyrazine kinase inhibitors |
| 05/29/2013 | EP2597087A1 Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors |
| 05/29/2013 | EP2597086A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 05/29/2013 | EP2595971A1 Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 05/29/2013 | EP2595966A2 Synthesis of cyclopentaquinazolines |
| 05/29/2013 | EP2595965A1 Insecticidal triazines and pyrimidines |
| 05/29/2013 | EP2595964A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/29/2013 | EP2595629A1 Pure erlotinib |
| 05/29/2013 | CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use |
| 05/29/2013 | CN103124557A 纯埃罗替尼 Pure erlotinib |
| 05/29/2013 | CN103121975A Preparation method of 5-fluorouracil drug intermediate |
| 05/29/2013 | CN103121974A Synthesis method of 5-fluorouracil drug intermediate |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121972A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121971A Salt for aryl urea derivant |
| 05/29/2013 | CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/29/2013 | CN101967127B Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs |
| 05/29/2013 | CN101696221B Substituted isoxazoles as fungicides |
| 05/29/2013 | CN101184734B Compound and methods of treating cell proliferation disorders |
| 05/28/2013 | US8450483 Pesticidal arylpyrrolidines |
| 05/28/2013 | US8450482 Process for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-([1-(N-methylcarbamoymethyl)piperidin-4-yl]oxy)quinazoline |
| 05/28/2013 | US8450333 Molecules for regulating cell death |
| 05/28/2013 | US8450327 CGRP antagonists |
| 05/28/2013 | US8450326 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| 05/28/2013 | US8450317 CXCR3 receptor antagonists |
| 05/28/2013 | US8450308 Inhibitors of beta-secretase |
| 05/28/2013 | US8449898 Fungicidal mixtures |
| 05/28/2013 | CA2720946C Compounds and compositions as protein kinase inhibitors |
| 05/28/2013 | CA2666196C Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2h)-pyrimidinyl]-4-fluoro-n-[[methyl-(1-methyl-ethyl)amino]sulphonyl]benzamide |
| 05/23/2013 | WO2013072758A1 Pyrimidine diol amides as sodium channel blockers |
| 05/23/2013 | US20130131341 Novel polymorphs of erlotinib hydrochloride and method of preparation |
| 05/23/2013 | US20130131093 Novel Dihydropyrimidin-2(1H)-One Compounds As Neurokinin-3 Receptor Antagonists |
| 05/23/2013 | US20130131075 New compounds |
| 05/23/2013 | US20130131036 Novel trpv3 modulators |
| 05/22/2013 | EP2594567A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 05/22/2013 | EP2594557A1 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 05/22/2013 | EP2594556A1 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 05/22/2013 | EP2593459A1 Process for the preparation of organic salts |
| 05/22/2013 | EP2593439A2 Process for preparing antiviral compounds |
| 05/22/2013 | EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 05/22/2013 | EP2593426A1 1-hydroxyimino-3-phenyl-propanes |
| 05/22/2013 | CN1993339B Aromatic compounds |
| 05/22/2013 | CN103119026A Process for preparing pan-cdk inhibitors of the formula (l), and intermediates in the preparation |
| 05/22/2013 | CN103119025A Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/22/2013 | CN103119022A Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| 05/22/2013 | CN103113349A 4-imidazolyl quinoline and quinazoline ketone aromatizing enzyme inhibitors as well as preparation method and medical application thereof |
| 05/22/2013 | CN103113311A 2-aryl quinazoline or 2-heterocyclic aryl quinazoline derivative and preparation method thereof |
| 05/22/2013 | CN103113310A Thiouracil derivative and application thereof |
| 05/22/2013 | CN103113309A Bipyrimidyl dibenzene/diether/diamine and synthesis method thereof |
| 05/22/2013 | CN103113308A Method for preparing dihydropyrimidinone derivative |
| 05/22/2013 | CN102190628B Preparation method of 5-fluoro-6-ethyl-4-hydroxypyrimidine intermediate and Voriconazole |
| 05/22/2013 | CN101903356B 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |
| 05/22/2013 | CN101088991B Process for preparing (S)-2-(2-carbonyl-tetrahydropyrimidyl-1-(2H)-base)-3-methyl butyric acid |
| 05/21/2013 | US8445677 Substituted pyrimidyl guanidine derivatives having anticancer activity |
| 05/21/2013 | US8445506 Polymorphs of lopinavir |
| 05/21/2013 | US8445497 Compounds for the treatment of hepatitis C |
| 05/21/2013 | US8445491 Wnt protein signalling inhibitors |
| 05/21/2013 | US8445480 CETP inhibitors derived from benzoxazole arylamides |
| 05/21/2013 | US8445408 Pyrimidine derivatives and their use for controlling undesired plant growth |
| 05/21/2013 | CA2699598C 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides |
| 05/21/2013 | CA2573223C Aromatic compound |
| 05/21/2013 | CA2428753C Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/16/2013 | WO2013070660A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/16/2013 | WO2013070620A1 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase |
| 05/16/2013 | WO2013068875A1 2-thiopyrimidinones |
| 05/16/2013 | US20130123498 Process for the preparation of etravirine and intermediates in the synthesis thereof |
| 05/16/2013 | US20130123496 Aryl urea derivatives as n-formyl peptide receptors like-1 (fprl-1) receptor modulators |
| 05/16/2013 | US20130123289 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 05/16/2013 | US20130123271 Heterocyclic compounds, their preparation and therapeutic application |
| 05/16/2013 | US20130123269 Novel heterocycle compounds and uses thereof |
| 05/16/2013 | US20130123230 2-Thiopyrimidinones |
| 05/16/2013 | US20130121919 Histone acetyltransferase activators and uses thereof |
| 05/16/2013 | CA2854836A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/16/2013 | CA2854329A1 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase |
| 05/16/2013 | CA2853024A1 2-thiopyrimidinones |
| 05/15/2013 | CN103102316A Preparation method of ZD1839Form1 crystal form |
| 05/15/2013 | CN103102315A Quinazoline arylurea and preparation method and application thereof |
| 05/14/2013 | US8440824 Method for producing pyrimidine compound |
| 05/14/2013 | US8440822 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 05/14/2013 | US8440681 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors |
| 05/14/2013 | US8440675 Potentiator of radiation therapy |
| 05/14/2013 | US8440666 Pyridazinone compounds and P2X7 receptor inhibitors |
| 05/14/2013 | US8440665 Apoptosis signal-regulating kinase inhibitors |
| 05/14/2013 | US8440663 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use |